[Acute lymphoblastic leukemia (ALL) of the T immunologic phenotype simulating a Burkitt-type ALL]

A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors.

medRxiv : the preprint server for health sciences·2025

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.

Thrombosis research·2021

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Journal of hematology & oncology·2018

Interferon alpha-2b for Essential Thrombocythaemia: Results in 13 Previously Untreated Patients.

Leukemia & lymphoma·2016

Adult T-cell Leukemia in a Chilean Resident in Spain: Long-Lasting Remission after 2-Deoxycoformycin Treatment.

Leukemia & lymphoma·2016

National climate policies across Europe and their impacts on cities strategies.

Journal of environmental management·2015

[Major thromboembolic complications during oral anticoagulant therapy. Importance of level of anticoagulation].

Sangre·2000

[MLL rearrangements in acute leukemias].

Sangre·2000

[Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].

Sangre·2000

[An analysis of transfusion in adult surgery].

Sangre·2000

[Pre and post-operative autotransfusion. A comparative study of hematology, biochemistry and red cell metabolism in pre-donated blood and blood from post-operative surgical drainage].

Sangre·2000

[Escherichia coli L-asparaginase induces phosphorylation of endogenous polypeptides in human immune cells].

Sangre·2000

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

Cureus·2026

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

ACS central science·2026

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Frontiers in immunology·2026

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

Frontiers in oncology·2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

BMC medicine·2026

Imaging features of soft tissue hibernoma: a review of 73 cases.

Skeletal radiology·2026

Related Experiment Videos

[Acute lymphoblastic leukemia (ALL) of the T immunologic phenotype simulating a Burkitt-type ALL]

Related Concept Videos

A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors.

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Interferon alpha-2b for Essential Thrombocythaemia: Results in 13 Previously Untreated Patients.

Adult T-cell Leukemia in a Chilean Resident in Spain: Long-Lasting Remission after 2-Deoxycoformycin Treatment.

National climate policies across Europe and their impacts on cities strategies.

[Major thromboembolic complications during oral anticoagulant therapy. Importance of level of anticoagulation].

[MLL rearrangements in acute leukemias].

[Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].

[An analysis of transfusion in adult surgery].

[Pre and post-operative autotransfusion. A comparative study of hematology, biochemistry and red cell metabolism in pre-donated blood and blood from post-operative surgical drainage].

[Escherichia coli L-asparaginase induces phosphorylation of endogenous polypeptides in human immune cells].

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

Imaging features of soft tissue hibernoma: a review of 73 cases.

Related Experiment Videos

[Acute lymphoblastic leukemia (ALL) of the T immunologic phenotype simulating a Burkitt-type ALL]

Related Concept Videos

Related Articles